Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most ...
Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one ...
A new nasal spray treatment being developed by FIU researchers could slow Parkinson's disease progression, offering hope for a major shift beyond symptom management.
Today, Aligning Science Across Parkinson's (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson's Research ...
Up to one in three people with Parkinson's disease use at least one psychotropic medication, a recent study from the ...
The future of treating brain diseases could lie in non-invasive technologies, according to Chongqing Haifu Medical Technology ...
There is no cure for Parkinson's Disease but Dr. Matt Main, a Functional Neurosurgeon from HCA HealthONE Swedish, talks about ...
A government-funded University of Malta research project called Minds is investigating the role of mitochondria in ...
UCL researchers have found that shifts in gut bacteria may be an important early signal to watch for to identify Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results